Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers

Title
Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
Authors
Keywords
Breast cancer, Tamoxifen, Oophorectomy, BRCA1, BRCA2
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 146, Issue 2, Pages 421-427
Publisher
Springer Nature
Online
2014-06-21
DOI
10.1007/s10549-014-3026-3

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search